Presentation - Novozymes

More documents

Recommendations

Info

Q1 2011 Financial Performance DKKm Q1, 2011 Q1, 2010 Absolute Development Index Sales 2,692 2,325 367 116 Gross profit 1,493 1,308 185 114 Gross margin 55.5% 56.3% EBIT (Operating profit) 635 535 100 119 EBIT margin 23.6% 23.0% Net profit 492 405 87 121 EPS (diluted) 7.67 6.35 1.32 121 Operating cash flow 683 483 200 141 Net investments excl. acq. 206 213 (7) 97 Free cash flow before acq. 477 270 207 177 Acquisitions 1,550 - 1,550 Free cash flow (1,073) 270 (1,343) Net interest-bearing debt 1,855 965 890 Net debt-to-equity 23.9% 15.7% Equity ratio 59.1% 55.1% ROIC, incl. goodwill 22.8% 24.6% 16
2011 Financial Outlook Guidance including the EMD acquisition Key financials 29.04.11 07.02.11 21.01.11 2010 Sales, DKKm - - - 9,724 Sales growth, DKK 8−11% 10−13% 7−10% 15% Sales growth, LCY 10−13% 10−13% 7−10% 10% Sales growth, organic 7−10% 7−10% 7−10% 11% EBIT, DKKm - - - 2,117 EBIT growth 8−11% 8−11% 8−11% 25% EBIT margin ~ 22% 21−22% 21−22% 21.8% Net profit - - - 1,614 Net profit growth 10−13% 8−11% 8−11% 35% Net investments, excl. acq., DKKm ~ 1,400 ~ 1,400 ~ 1,400 1,326 Free cash flow bef. acq., DKKm 1,000− 1,100 900− 1,000 900− 1,000 998 ROIC ~ 21% ~ 20% 21−22% 22.2% 17
Page 1 and 2: SUSTAINABILITY AS A BUSINESS DRIVER
Page 3 and 4: Agenda Overview of Novozymes Novozy
Page 5 and 6: Delivering Tomorrow‟s Solutions T
Page 7 and 8: Undisputed Market Leader Expanding
Page 9 and 10: 1. Innovation-driven Top-Line Growt
Page 11 and 12: 3. Leveraging Expertise Generates O
Page 13 and 14: BioBusiness - Q1 2011 Exciting Proj
Page 15: Performance Overview by Segment, Q1
Page 19 and 20: NOVOZYMES AND SUSTAINABILITY
Page 21 and 22: Novozymes‟ Sustainability Journey
Page 23 and 24: Novozymes‟ Sustainability Organiz
Page 25 and 26: Sales & Marketing: Use of sustainab
Page 27 and 28: TARGETS AND PERFORMANCE
Page 29 and 30: Sustainability Targets and Achievem
Page 31 and 32: Employee Data - Geographical Overvi
Page 33 and 34: ENVIRONMENT
Page 35 and 36: Decoupling Use of Resources from Ec
Page 37 and 38: LCAs Address Four Environmental Cat
Page 39 and 40: Our Products Help Reduce CO 2 acros
Page 41 and 42: Regular Bread vs. Enzymatically Pro
Page 43 and 44: OTHER SUSTAINABILITY ISSUES
Page 45: Contacts Martin Riise Investor Rela
Page 48 and 49: Responsible Purchasing: Novozymes
Page 50 and 51: Human Capital and Incentive Structu
Page 52 and 53: Novozymes‟ Business Integrity Man
Page 54 and 55: Novozymes as a Corporate Citizen Co
Page 56 and 57: GMO and Microorganisms Enzymes - a
Page 58 and 59: What are Enzymes • Enzymes can be
Page 60 and 61: Novozymes‟ use of Gene Technology
Page 62 and 63: GM Microorganisms Examples: • Tai
Page 64: Novozymes‟ Use of Industrial Biot

Presentation - Novozymes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?